DOI: 10.1111/bjh.14775

,  

,  

PMID: 28542714

MEDLINE Status: Publisher

Issn Electronic: 1365-2141


Print

Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma.

Rie S Bech; Kasper L Nielsen; Thomas S Larsen; Hans H Bentzen; Line S Lynggaard; Trung H Do; Peter Braendstrup; Jessica Brady; N George Mikhaeel; Karen Dybkaer; Hans E Johnsen; Paw Jensen; Martin Bøgsted; Tarec C El-Galaly

+ Author Information

Author Information: Department of Medicine, Regionshospitalet Nordjylland, Hjørring, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Haematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Haematology, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Oncology, Guy's and St Thomas' Hospital, London, England.; Department of Clinical Oncology, Guy's and St Thomas' Hospital, London, England.; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles